We probably only need one of the insurers to break ranks. Then the others will surely have to follow. They have to be able to justify their policies given the push to stem cells, although he's not much of a process person it's possible RFK Jnr will have a word. The CEO of Allied Health found out the hard way what the consequences can be to being perverse with policy conditions and refusals as not medically necessary. JIMO.
MSB Price at posting:
$2.80 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)